Home  |  Investor News | Careers |  Useful Links  |  Sitemap
 
 
     
  Publications and
Press Releases
 
     
 

AlphaBeta Pharma Appoints
a Head for its Clinical Operations.

AlphaBeta Pharma Strengthens its European Presence by Opening a New Office in Turkey.

AlphaBeta Pharma Strengthens its Presence in the Middle-East by Acquiring a Cairo-based CRO.

AlphaBeta Pharma forms a strategic alliance with Mena Research CRO.

 
     
  Read more  
 
     
  News & Events  
     
 

Pharmaceutical Distributers
Urgently Needed in Middle East, Turkey, Israel and South Africa

AlphaBeta Pharma will be
present at “Phase I Clinical Trials Summit” On 28th – 29th October 2010, BSG Conference Centre, London, UK

AlphaBeta Pharma will be
present at “Accelerating Early Clinical Development
Conference”

AlphaBeta Pharma will be
present at “Drug Delivery Partnerships and the Latest Innovations Conference”

 
     
  Read more  
 
 
 
 
 
 
 
 
 
Our products pipeline is diverse, from therapeutics to diagnostics, and changes over time as new molecules and devices progress from discovery to development and ultimately to approval where they become available to patients.
 
 

Indication

Project

Partnership

Preclinical

Phase
I

Phase
II

Phase
III

Registration

 
Schizophrenia AB-1005-01/MRTU Government fund
 
 

 

 

 

Pain AB-1110-21/WREA Investors fund
 
 

 

 

 

Oncology AB-3020-01/MRHB Academic fund
 

 

 

 

Infection AB-4030-21/YBYS Investors fund
 

 

 

Diagnostic AB-3025-11/MRHB Academic fund
 

 

 

 

 

GI AB-2115-21/NRMR Investors fund